Suvorexant (Belsomra® Tablets 10, 15, and 20 mg): Japanese Drug-Use Results Survey

Yuko Asai(MSD K.K. (Japan)), Mitsuyoshi Hara(MSD K.K. (Japan)), Makoto Miyazaki(Chiba Cancer Center), Mika Iwakura(MSD K.K. (Japan)), Yoshikazu Maeda(Fukui Prefectural Hospital), Hideki Sano(MSD K.K. (Japan))
Drugs in R&D
December 14, 2018
Cited by 22


Related Papers